Juva Life Inc. (JUVAF)
OTC
Healthcare
Drug Manufacturers - Specialty & Generic
$0.00
▲ +0.00%
Market Cap
$1,641
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
-8.58
52-Wk Range
0.00001-0.0012
CEO
Mathew Lee
Country
CA
Currency
USD
Juva Life Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $1,641. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -181.9%. Its beta of -8.58 implies it has historically moved less than the broad market.
Valuation & profitability (TTM)
P/E
-0.00
Price / Sales
0.00
Price / Book
0.00
EV / EBITDA
-1.08
Gross margin
0.8%
Operating margin
-140.9%
Net margin
-181.9%
Return on equity
—
Debt / equity
0.82
Current ratio
1.11
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
0
IPO date
2021-01-08
Headquarters
Vancouver, BC, CA
About Juva Life Inc.
Juva Life Inc. is engaged in the cannabis industry, overseeing the acquisition, ownership, and management of businesses within both the medical and adult-use sectors. The company was founded in 2018 and has its principal offices located in Vancouver, Canada.
Comparable companies
Juva Life Inc. is most often compared with the following Healthcare names:
More research on JUVAF
Open full interactive analysis & DCF →